Compare PSX & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PSX | ELV |
|---|---|---|
| Founded | 1875 | 1944 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.4B | 88.0B |
| IPO Year | 2011 | 2001 |
| Metric | PSX | ELV |
|---|---|---|
| Price | $289.30 | $427.80 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 22 |
| Target Price | $276.84 | ★ $451.71 |
| AVG Volume (30 Days) | ★ 2.8M | 1.1M |
| Earning Date | 10-28-2026 | 10-21-2026 |
| Dividend Yield | ★ 1.76% | 1.61% |
| EPS Growth | ★ 116.23 | N/A |
| EPS | 10.05 | ★ 14.73 |
| Revenue | $132,376,000,000.00 | ★ $199,125,000,000.00 |
| Revenue This Year | $29.89 | N/A |
| Revenue Next Year | N/A | $1.93 |
| P/E Ratio | ★ $28.77 | $29.05 |
| Revenue Growth | N/A | ★ 12.49 |
| 52 Week Low | $126.92 | $274.89 |
| 52 Week High | $297.42 | $436.24 |
| Indicator | PSX | ELV |
|---|---|---|
| Relative Strength Index (RSI) | 70.93 | 68.36 |
| Support Level | $166.52 | $380.43 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 7.15 | 9.91 |
| MACD | 2.09 | 3.90 |
| Stochastic Oscillator | 93.64 | 94.44 |
Phillips 66 is an independent refiner that owns or holds interest in 10 refineries with a total crude throughput capacity of 2.0 million barrels per day, or mmb/d, at the end of 2025. The midstream segment comprises extensive transportation and NGL processing assets. It includes 70,000 miles of crude oil, refined petroleum product, NGL and natural gas pipeline systems, and a comprehensive set of refined petroleum product, NGL and crude oil terminals, gathering and processing plants and fractionation facilities and various other storage and loading facilities. Its CPChem chemical joint venture operates facilities primarily in the United States and the Middle East and produces olefins and polyolefins.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.